No Data
Dirui Industrial (300396.SZ): The products do not involve ai.
Gelonghui December 4th: dirui industrial (300396.SZ) stated on the investor interaction platform that the company's products do not involve ai.
Dirui Industrial (300396): Performance under pressure in stages, expecting a surge in reagents.
Subject: The company released the third quarter report of 24 years, Q1-3 of 24, with revenue of 1.175 billion yuan (+12.10%), net income attributable to the mother of 0.193 billion yuan (-17.80%), non-net profit of 0.188 billion yuan (-)
Express News | Dirui Industrial: Shareholders plan to reduce their shareholding by no more than 1.98% of the company's shares
Diri Healthcare: Report for the third quarter of 2024
dirui industrial (300396.SZ): net income in the first three quarters was 0.19 billion yuan, a year-on-year decrease of 17.8%.
Gelonghui October 24th | Dirui Industrial (300396.SZ) announced its third-quarter report, with revenue of 1.175 billion yuan in the first three quarters, a year-on-year increase of 12.10%, net income of 0.19 billion yuan, a year-on-year decrease of 17.8%, non-GAAP net income of 0.188 billion yuan, a year-on-year decrease of 17.72%, and basic earnings per share of 0.7062 yuan.
Dirui Industrial (300396.SZ): Africa is one of the company's global strategic markets with channel construction completed in East Africa and North Africa.
Dirui Medical (300396.SZ) stated on the investor interaction platform on September 6th that Africa is one of the company's strategic markets. The construction of channels in East Africa and North Africa has been completed, and the company has previously won the MOH basic medical bidding project in Tanzania. Overall, the revenue scale in Africa is currently small, but it is gradually growing, and there is uncertainty about its impact on the company's performance.
